by David Alcántara | Jan 4, 2022 | News
The United States Patent and Trademark Office (USPTO) just granted our patent that protects LIM21 and its uses in ocular diseases. This is an important step in our IP strategy since the USA market is one of the most important ones in the world.
by David Alcántara | Apr 14, 2021 | News
Limnopharma has been awarded as one of the 5 finalists in the Startup Andalucía Roadshow program, awarding the most innovative startups companies in Andalucia. The other awardees have been Myhixel, OWO games, Scoobic Urban Mobility and Wuolah. The five winners will...
by David Alcántara | Dec 20, 2020 | News
Limnopharma is awarded with a Research Project funded by the NEOTEC program (CDTI; Spanish Ministry of Science and Innovation), for new Business Projects from innovative Start-up companies. The project granted includes a series of experiments for the preclinical...
by David Alcántara | Oct 20, 2020 | News
Limnopharma signs a Research Agreement with “Fundación Progreso y Salud”, an organization which belongs to the Andalusian Region Ministry of Health (Spain). The agreement includes the execution of the “Lead retina” research project, led by Dr. Dr. Díaz-Corrales, to...
by David Alcántara | Aug 20, 2020 | News
In August 2020, Dr. Diego del Río Días-Jara and Dr. Claudio Punzo join Limnopharma’s Scientific Advisory Board. Diego del Río holds a PhD. In Chemistry and is an expert in business development and market analyses. Claudio Punzo is Associate Professor at the University...
